Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT01336348

Completed

Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse (FABOLUS PRO)

ST Segment Elevation Myocardial Infarction
NCT00349336

Completed

A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.

Colorectal Cancer
NCT00680498

Completed

Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment (CLOVER)

Age-Related Macular Degeneration
NCT00399750

Completed

TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer

Colorectal Cancer
NCT00828776

Completed

Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure (heparin)

Chronic Renal Failure
NCT00303420

Terminated

Alteplase for Blood Flow Restoration in Hemodialysis Catheters

Thrombosis
NCT00596297

Completed

Preoperative Bevacizumab for Vitreous Hemorrhage (IBEVI)

Diabetic Retinopathy | Vitreous Hemorrhage
NCT00523263

Completed

Dacron vs Dardik for Fem-Pop Bypass (DaDa)

Arterial Occlusive Diseases | Intermittent Claudication | Atheroslerosis
NCT00396045

Completed

Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma

Multiple Myeloma
NCT03979625

Completed

Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation (TIH ECMO)

Heparin-induced Thrombocytopenia
NCT03558750

Terminated

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Central Nervous System Lymphoma | Recurrent Central Nervous System Lymphoma
NCT01118039

Unknown

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
NCT07018947

Not yet recruiting

Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC (ASPIRE)

Resectable Hepatocellular Carcinoma
NCT05965154

Not yet recruiting

Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma
NCT05825573

Active, not recruiting

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus (ARGONAUT)

Heart Failure | STEMI | Intracardiac Thrombus
NCT02681549

Completed

Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)

Melanoma | Non-small Cell Lung Cancer | Brain Metastasis
NCT04217967

Completed

Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients

Multiple Myeloma
NCT04669366

Completed

Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries

Kidney Neoplasms
NCT00330564

Terminated

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

Renal Cell Carcinoma | Von Hippel-Lindau Syndrome | Hemangioblastoma
NCT03475004

Active, not recruiting

Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer

Colorectal Cancer | Metastatic Cancer
NCT01137604

Completed

A Study in Subjects With Recurrent Malignant Glioma

Glioma
NCT01164202

Completed

Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer (SATURNE)

Liver Cancer
NCT04393220

Completed

Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

Progress Free Survival (PFS) and Overall Survival (OS)
NCT03909724

Unknown

Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC) (SUNRISE-CRC)

Colorectal Cancer | Metastasis
NCT00783653

Completed

Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years

Acute Myeloid Leukemia
NCT00378911

Completed

Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

Recurrent Uterine Sarcoma | Uterine Leiomyosarcoma
NCT00910910

Completed

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) (ORIGIN)

B-Cell Chronic Lymphocytic Leukemia
NCT01403246

Terminated

Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia
NCT01924169

Terminated

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

Hematologic Disorder
NCT01158222

Completed

Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Clear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer
NCT01705002

Completed

Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.

Cancer | Solid Tumor | Metastatic Colorectal Cancer (mCRC)
NCT00805805

Completed

Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis

Primary Biliary Cirrhosis
NCT00872014

Completed

A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer

Advanced Hepatocellular Carcinoma | Inoperable Hepatocellular Carcinoma
NCT02179567

Terminated

Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC

NSCLC
NCT00980213

Completed

Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland

Neoplasms | Renal Cell Carcinoma
NCT00457392

Completed

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

Carcinoma, Non-Small Cell Lung
NCT00489437

Completed

Heparin-Induced Thrombocytopenia Score Card Study

Heparin-Induced Thrombocytopenia
NCT01081613

Completed

Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)

Breast Cancer
NCT00405574

Unknown

Study of ATN-224 in Patients With Prostate Cancer

Prostate Cancer
NCT07248462

Not yet recruiting

Integrating Mental Health Into Neglected Tropical Disease Care in Ghana (IMAGINE)

Onchocerciasis | Yaws | Leprosy | Lymphatic Filariases | Buruli Ulcer
NCT06089473

Recruiting

Virtual Home-based Physical Pre-habilitation in Kidney Transplant Candidates

Frailty | Transplant;Failure,Kidney | Kidney Disease, End-Stage
NCT06442969

Completed

Implementing an Intervention to Reduce Heat Stress and Chemical Exposures

Dehydration | Heat Stress
NCT04540081

Completed

Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer (CLOVER)

Obesity | Hepatitis C | Lung Cancer | Pneumonia, Bacterial | Tobacco Use Cessation | Colon Cancer | Shingles
NCT06290596

Not yet recruiting

Vasopressin Versus Tranexamic Acid for Control of Blood Loss Related to Abdominal Hysterectomy

Uterine Surgery
NCT04803994

Recruiting

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

Hepatocellular Carcinoma
NCT03760822

Active, not recruiting

Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients (SOCRATE)

Stomach Cancer | Gastric Cancer | Gastroesophageal Junction Adenocarcinoma | Stomach Neoplasm
NCT03733691

Terminated

Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM Patients

Newly Diagnosed Multiple Myeloma
NCT03379051

Terminated

Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL and NHL

Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma
NCT03953079

Completed

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD (ALTISSIMO)

Neovascular Age-Related Macular Degeneration
NCT00975806

Terminated

Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma

Renal Cell Carcinoma

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations